Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
The Food and Drug Administration (FDA) is issuing an interim final rule to amend certain regulations regarding the screening and testing of donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps), and related labeling. FDA is taking this action in response to comments from affected interested persons regarding the impracticability of complying with certain regulations as they affect particular HCT/Ps.
D001688:Biological Products / Q000592:standards*; D003140:Communicable Disease Control / Q000592:standards; D046148:Donor Selection / Q000331:legislation & jurisprudence*; D006801:Humans; D011356:Product Labeling / Q000331:legislation & jurisprudence*; D014019:Tissue Donors / Q000331:legislation & jurisprudence*; D019737:Transplants / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products